Dr. Hemant Sreenivasa Murthy, MD

Dr. Murthy practices at Mayo Clinic Hospital in Jacksonville, Florida, part of Mayo Clinic.

Dr. Murthy's NPI, 1518129188, was assigned on June 25, 2008. Dr. Murthy graduated from St. George's University School of Medicine in 2008. Dr. Murthy holds Florida license ME124262.

Dr. Murthy's primary practice is Mayo Clinic Hospital, at 4500 San Pablo Rd, Jacksonville, FL 32224 in Duval County. The practice phone is (904) 953-2000.

Dr. Murthy's primary practice is Mayo Clinic Hospital in Jacksonville, Florida, part of Mayo Clinic. The medical group on file is Mayo Clinic Jacksonville.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Murthy practices. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Murthy's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Murthy is board certified in hematology by the American Board of Internal Medicine. Dmand AI has Dr. Murthy's licenses on file in 3 states: Florida, North Carolina and Virginia.

Dmand AI lists breast cancer, chronic anemia, chronic leukemia, lung cancer, lymphoma, multiple myeloma and prostate cancer among the conditions Dr. Murthy treats.

CMS data shows 65,049 Medicare services from Dr. Murthy across 55 procedure codes in 2024, for 698 Medicare patients. Medicare paid $1,170,987 for them.

CMS counts 698 Medicare patients who saw Dr. Murthy in 2024. The largest group is 65 to 74, with 364 patients. 73% of them have high cholesterol, and 72% have high blood pressure. 5% are also on Medicaid. Their average risk score is 2.62, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Murthy's median patient age at 66, with 49% women.

In 2024, Dr. Murthy wrote 553 Medicare Part D claims for 42 patients. 79% of them were for generic drugs. CMS names the drug for 358 of them, across 18 drugs with 11 or more claims each, at $1,090,707 in total drug cost. In 2023, CMS named 196 claims across 10 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Dr. Murthy for performance year 2024, reported as part of a group. Dr. Murthy accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Murthy as offering telehealth.

Dmand AI links 103 papers to Dr. Murthy, published from 2017 to 2025. 2023 was the busiest year, with 17. The most frequent topics are Hematopoietic Stem Cell Transplantation, Immunotherapy, Adoptive and Receptors, Chimeric Antigen. Dr. Murthy has published most often in Transplant Cell Ther. Dr. Murthy's most frequent co-authors are James M. Foran, MD, Madiha Iqbal, MBBS and Mark R. Litzow, MD.

Dmand AI links Dr. Murthy to 1 clinical trial. Conditions studied include Myelodysplastic Syndromes and Bone Marrow Diseases.

CMS Open Payments shows 90 general payments to Dr. Murthy from 26 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 85% of the total. Kite Pharma, Inc. paid the most, $15,672.

Dmand AI lists 2 awards for Dr. Murthy, most recently AAHPM HPNA Annual Assembly Palliative Medicine Access Fund Scholarship in 2012.

Dr. Murthy graduated from St. George's University School of Medicine in 2008. Dr. Murthy is a member of American Association of Hospice and Palliative Medicine, ACP, AMA, ASCO, ASH and American Society of Neurooncology.

Dr. Murthy is in network with 9 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. HMO plans come from the most carriers, 5. Check the plan with the practice before a visit.